Inspiration Healthcare Group Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BXDZL105
GBP
0.20
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Inspiration Healthcare Group Plc stock-summary
stock-summary
Inspiration Healthcare Group Plc
Pharmaceuticals & Biotechnology
Inspiration Healthcare Group plc, formerly Inditherm plc, is a supplier of medical devices mainly in areas of critical care. The Company operates through four segments: Critical Care, Operating Theatre, Home Healthcare, and Central and Unallocated costs. Under the Critical Care segment, the Company's products for premature and sick babies include LifeStart (for deferred cord clamping), Tecotherm Neo (for thermoregulation) and Inspire nCPAP (non-invasive respiratory support). It also sells products for adult and pediatric intensive care in the United Kingdom and Ireland. Under the Operating Theatre segment, the Company's products include the Inditherm Alpha system and a range of warming products for maintaining patient temperature during surgery. Under the Home Healthcare segment, the Company's products include the Inditherm industrial products and a range of products mainly for parenteral feeding and products that are not used in intensive care and the operating theatre.
Company Coordinates stock-summary
Company Details
2 Satellite Business Village , CRAWLEY None : RH10 9NE
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Mark Abrahams
Non-Executive Chairman of the Board
Mr. Neil Campbell
Chief Executive Officer, Executive Director
Mr. Toby Foster
Executive Director, Commercial Director
Ms. Liz Shanahan
Non-Executive Director
Mr. Robert Beveridge
Senior Independent Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 18 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.43

stock-summary
Return on Equity

1.05%

stock-summary
Price to Book

1.08